Orion Oyj, previously Orion Corporation, is a Finland-based company active within the pharmaceutical industry. The Company is engaged in the research and development, manufacture and marketing of human and veterinary pharmaceuticals and active pharmaceutical ingredients. The core therapy areas of the Company's pharmaceutical R&D are central nervous system (CNS) disorders, oncology and respiratory diseases.
Key people
Liisa Hurme
President, Chief Executive Officer, Member of the Executive Management Board
Rene Lindell
Chief Financial Officer, Member of the Executive Management Board
Julia Irene Macharey
Senior Vice President - People and Culture, Member of the Executive Management Board
Satu Ahomaki
Senior Vice President, Generics and Consumer Health, Member of the Executive Management Board
Juhani Kankaanpaa
Senior Vice President, Global Operations, Fermion, Member of the Executive Management Board
Niclas Lindstedt
Senior Vice President, Animal Health, Member of the Executive Management Board
Hao Pan
Senior Vice President, Branded Products, Member of the Executive Management Board
Outi Vaarala
Senior Vice President for Research and Development and Innovative Medicines, Member of the Executive Management Board
Jani Korhonen
Employee Representative on the Executive Management Board
Mikael Silvennoinen
Independent Chairman for the Board
Hilpi Rautelin
Independent Vice Chairman of the Board
Kari Jussi Aho
Independent Director
Maziar Mike Doustdar
Independent Director
Ari Lehtoranta
Independent Director
Click to see more
Key facts
Industry
Biotechnology & Drugs
Exchange
Helsinki Stock Exchange
Index
Finland-OMX-Helsinki-All-Share